Physician profile
Oresta Bilous
NPI 1609016146
$4,066.09
in general payments reported to CMS, 2019-2025
8 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $202 · 2021: $433 · 2022: $1,886 · 2023: $726 · 2024: $77.92 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072 · Gift: $82.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.08 |
| Gift | $82.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,055.43 | 2019-2023 | Touch Up, Invisalign, Invisalign First - Comprehensive |
| American Orthodontics Corporation | $673.75 | 2019-2025 | Empower-Metal, LP and Ifit Tubes, Radiance |
| Ormco Corporation | $646.27 | 2021-2023 | Spark, Miniendo II |
| Envista Holdings Corporation | $304.61 | 2024-2025 | Damon, Spark |
| Nobel Biocare USA | $263.90 | 2023 | Nobelactive |
| Lightforce Orthodontics, INC. | $86.59 | 2022-2023 | |
| 3m Company | $21.77 | 2020 | |
| Ortho Organizers, INC. | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oresta Bilous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.